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CASE PRESENTATION
A 71-year-old Hispanic woman presented to our medical
center with a general sense of feeling ‘unwell.’ She suffered
from multiple medical conditions, including long-standing
history of diabetes, hypertension, hypercholesterolemia,
depression, and end-stage renal disease (ESRD) for which
she has been on dialysis for the last 3 years. Seven years
prior to her current admission, the patient presented with an
acute onset of left seventh nerve palsy associated with
hypercalcemia and submandibular and perihilar lymphade-
nopathy. Submandibular lymph node biopsy showed infiltra-
tion with a polymorphous population of lymphocytes and
granulomas, findings consistent with sarcoidosis. She was
treated with a course of corticosteroids and methotrexate,
with complete resolution of symptoms within 2 years of the
diagnosis. Steroids were discontinued 6 years and methotre-
xate 4 years before her current admission. Her sarcoidosis
remained in complete remission. Her past medical history
was also significant for primary hyperparathyroidism; she
underwent partial parathyroidectomy in the early 1980s. The
patient’s kidney disease had been diagnosed 4 years prior,
when she presented with a nephrotic syndrome and
creatinine (Cr) of 1.5 mg per 100 ml (ref. 0.5–0.9 mg per
100 ml). The kidney biopsy performed at that time revealed
advanced focal segmental glomerulosclerosis and she
progressed to ESRD within 1 year of the diagnosis. Over the
last 3 years, the patient has been maintained on regular
thrice-weekly hemodialysis through a radial arteriovenous
fistula with adequate clearance (urea reduction ratio ranging
from 77 to 84%) and no major complications.
The patient was brought to the emergency room by
her family for unstable gait with ‘dance-like’ quality. The
symptoms developed gradually over the period of 2 days.
The patient neither missed dialysis nor had been ill, and
had no sick contacts. Her medication regimen included
aspirin, diltiazem, paroxetine, statin, glipizide, sevelamer,
multivitamins, and stool softeners. She denied any
exposure to antipsychotics or antiemetics. There was no
family history of movement disorders, psychiatric disease,
or renal disease. The patient used to work as a seamstress
and retired several years ago. She did not smoke or drink
and denied any illicit substance use.
The patient’s pulse was 82–88 per min and the blood
pressure ranged from 130/70 to 180/80 mm Hg in the
emergency room. The head and neck, cardiopulmonary,
and abdominal examinations were normal. There was no
extremity edema, and pulses were intact. She was alert and
oriented to person, place, date, and current events. Her
speech was fluent. Naming, repetition, and reading were
intact. She was able to follow three-step commands and
her memory was not affected. Her cranial nerves were
also intact. Muscular examination revealed normal tone,
full-strength, and intact deep tendon reflexes. She
exhibited no asterixis or myoclonus. Her gait was
unstable with wide stance and exaggerated steps with
a dance-like quality. While at rest, she exhibited slow
involuntary choreoathetotic movements. The movements
ceased during sleep or after treatment with intravenous
diphenhydramine in the emergency room, but reappeared
upon awakening.
Her initial laboratory evaluation revealed normal
blood counts and serum electrolytes, Cr 5.8 mg per 100 ml
(ref. 0.5–0.9 mg per 100 ml), BUN 34 mg per 100 ml (ref.
7–20 mg per 100 ml), and glucose 110 mg per 100 ml (ref.
70–105 mg per 100 ml). She had normal liver and thyroid
function tests and negative urine toxicology screen. Other
studies, including the electrocardiogram and chest and
abdominal radiographs, were all within normal limits.
A computed tomography scan of the head without
contrast was performed and, upon comparison to a prior
scan 4 years earlier, was suggestive of new poorly defined
lucencies in the basal ganglia region (Figure 1a).
This study was followed by a magnetic resonance
imaging (MRI), which revealed symmetric bilateral
hyperintensity of putamen and globus pallidus on
FLAIR and T2 sequences (Figure 1b). These changes
corresponded to the hypodensities seen on the computed
tomography scan and were not present on an MRI scan
done 1 year before. There was no evidence of contrast
uptake on T1 gadolinium-enhanced images. Magnetic
resonance angiography was unremarkable.
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DIFFERENTIAL DIAGNOSIS
Chorea is characterized by involuntary, nonrepetitive,
adventitious muscular contractions. It originates from a
dysfunction of neuronal networks interconnecting basal
ganglia and frontal motor cortex. A wide range of conditions
have been associated with sporadic chorea.1 The conditions
that are relevant to the presentation of our patient, an elderly
diabetic with ESRD, include acute basal ganglia ischemia
(although large vessel cerebrovascular disease was excluded
by imaging in this case), exposure to toxins and pharmaco-
logic agents affecting dopaminergic neuronal pathways (none
detected by history in this case), hereditary neurodegenera-
tive disease (such as late-onset Huntington’s disease and
related hereditary disorders), as well as various metabolic,
autoimmune, inflammatory, infectious, and neoplastic con-




Figure 1 | Brain Imaging. (a) Admission computed tomography scan demonstrates new low-density regions in the basal ganglia;
(b) admission T2/FLAIR MRI image with extensive symmetric areas of increased signal intensity within bilateral basal ganglia;
(c) a follow-up T2/FLAIR MRI scan performed 6 weeks after the initial presentation demonstrates complete resolution of T2-weighted
signal abnormalities.
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electrolyte abnormalities associated with kidney disease, renal
replacement therapy, and diabetes may be involved in basal
ganglia toxicity. Specifically, these include severe uremia,
rapid correction of dysnatremia, acidosis, and severe hypo- or
hyperglycemia. None of the above problems are present in
this patient, who had been on adequate dialysis treatments
without any evidence of serious metabolic abnormalities.
A neurological consultation and hospital admission for a
Table 1 | Differential diagnosis for basal ganglia lesions in a hemodialysis patient
Cause Mechanism/Comments Workup in this case
Hereditary
Late-onset Wilson’s disease Autosomal recessive defect in cellular copper
transport
No hepatic disease, no cognitive changes, no
corneal rings, spontaneous resolution
Late-onset Huntington’s disease and
related genetic disorders2
Progressive neurodegenerative disorders
characterized by chorea, cognitive decline, and
behavioral changes
Negative family history, no behavioral or
cognitive impairment, spontanous resolution
Endocrine
Hyperthyroidism Unknown mechanism Normal thyroid function tests
Fahr’s syndrome Calcification of the basal ganglia No calcifications in the basal ganglia by imaging
Electrolyte/metabolic disorders
Hypo/hypernatremia3,4 Basal ganglia edema/extrapontine myelinolysis Normal serum Na levels, no history of dysnatremia
Hypo/hyperglycemia5–8 Very rare cause of isolated chorea Normal serum glucose levels, HgbA1C 7.8%
Organic acidosis9,10 Unclear mechanism, rare Normal bicarbonate, no anion gap
Uremia/hemodialysis1,11–16 Chronic kidney disease, underdialysis Stable and adequate dialysis treatments
Thiamine deficiency17 Malnutrition Normal serum thiamine levels
Drugs and toxins
Pharmacologic agents2 Antipsychotic, anti-Parkinsonian, and antiepileptic
agents, verapamil, baclofen, tricyclics, lithium,
theophylline, digoxin, cyclosporine, steroids, OCPs
Not taking
Psychostimulants Cocaine, amphetamines Negative toxicology screen
Alcohols Ethanol, methanol,18 ethylene glycol19 Negative toxicology screen
Carbon monoxide20 Hypoxic basal ganglia injury Normal carboxyhemoglobin levels
Manganese,21 Aluminum,22 Lead Direct basal ganglia toxicity Normal serum levels
Vascular
Cerebrovascular disease Thrombosis/infarction Normal MRA, symmetric bilateral lesions
Polycythaemia vera Hyperviscosity/infarction Normal hematocrit
HUS/TTP Microthrombosis/infarction No hemolysis, normal platelet count
Moyamoya disease Progressive arterial occlusive disease, likely
hereditary
Normal MRA, no family history
Post-pump chorea23 Complication of extracorporeal circulation No documented intradialytic hypotension
Autoimmune/inflammatory
SLE Vasculitis/inflammation Negative autoimmune serologies, normal
complement levels, no systemic symptoms.
APS Thrombosis/infarction Negative APL/ACL serologies
Small vessel vasculitis Vasculitis/inflammation Negative ANCA, normal CRP, no systemic symptoms.
Multiple sclerosis plaques Demyelination/inflammation No evidence of plaques on imaging, CSF fluid
negative for oligoclonal bands
Sydenham’s chorea Rheumatic fever, typically in childhood, antibody-
mediated (molecular mimicry between
streptococcal and CNS antigens)
Negative ASO titers, advanced age, no evidence
of rheumatic fever
Postinfectious or postviccinal encephalitis Autoimmune reaction following exposure to
foreign antigens (molecular mimicry)
No history of recent infections or vaccinations
Neurosarcoidosis24 Granulomatous inflammation may rarely involve
basal ganglia
No evidence of sarcoidosis on MRI, lack of systemic
symptoms, normal ACE levels
Infections
HIV/AIDS Possible direct HIV infection of subcortical
structures
Negative HIV test
Neurosyphilis Direct infection in the basal ganglia Negative RPR and CSF VDRL
Bacterial endocarditis Typically unilateral septic embolic disease Bilateral lesions, no evidence of endocarditis
Parasitic infections and TB Toxoplasmosis, cysticercosis, tuberculous
granulomas
No evidence by imaging, negative PPD
Creutzfeldt–Jakob Disease Sporadic human prion disease Negative CSF 14-3-3 protein, spontaneous resolution
Tumors
Mass lesions CNS lymphoma or metastatic lesions No evidence of tumor on imaging
Paraneoplastic syndromes Anti-Hu and anti-CRMP5 antibodies Negative paraneoplastic antibody panel
ACE, angiotensin converting enzyme; ACL, anti-cardiolipin; ANCA, anti-neurtophilic cytoplasmic antibodies; APL, anti-phospholipid; APS, anti-phospholipid syndrome;
ASO, anti-streptolysin O; CNS, central nervous system; CRP, C-reactive protein; CSF, cerebrospinal fluid; Hgb, hemoglobin; HUS, hemolytic uremic syndrome; MRA,
magnetic resonance angiogram; MRI, magnetic resonance imaging; OCPs, oral contraceptive pills; PPD, purified protein derivative; RPR, rapid plasma reagin; SLE, systemic
lupus erythematosus; TB, tuberculosis; TTP, thrombotic thrombocytopenic purpura; URR, urea reduction ratio; VDRL, veneral disease research laboratory.
Only selected relevant causes are referenced.
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complete workup of possible etiologies are warranted in
this case.
CLINICAL FOLLOW-UP
The patient was admitted to the hospital, neurological
consultation was obtained, and a lumbar puncture was
performed. The opening pressure was 22 cm H2O and
cerebrospinal fluid was clear and contained 39 RBCs per
mm3 with no visible WBCs. Cerebrospinal fluid glucose was
100 mg per 100 ml (ref. 40–70 mg per 100 ml) and protein
was 47 mg per 100 ml (ref. 15–45 mg per 100 ml). Other
negative cerebrospinal fluid studies included bacterial, fungal,
and AFB cultures, VDRL, Lyme PCR, viral encephalitis panel,
oligoclonal banding, paraneoplastic antibody panel, and 14-
3-3 protein. Serum tests for aluminum, cyanide, manganese,
lead, and carboxyhemoglobin were all within normal limits.
Other negative tests included rheumatoid factor, C-reactive
protein, RPR, PPD, Lyme antibody test, ANA, anti-dsDNA,
ANCA, hepatitis panel, antibodies to SSA, SSB, U1RNP, Sm,
Scl-70, and Jo-1 antigens. The results of additional workup
are summarized in Table 2. While in the hospital, the patient
was dialyzed three times a week, with adequate clearance and
no episodes of intradialytic hypotension. Her neurologic
symptoms improved gradually with conservative manage-
ment. On the sixth day of her admission, she was transferred
to an in-patient rehabilitation facility. Her symptoms
resolved completely within 12 days, and she was discharged
home in a stable condition. An MRI scan performed 6 weeks
after the initial presentation demonstrated complete resolu-
tion of abnormal T2 signal intensities (Figure 1c) and there
was no recurrence of symptoms after 1 year of follow-up.
DISCUSSION
There are only a handful of case reports of acute
extrapyramidal movement disorders in patients with ESRD
on dialysis. Most of the reports came from the Asian
continent (12 cases from Taiwan,11–13 2 cases from Korea,14,15
and 1 case from Japan16). Only one European case has been
reported to date in a diabetic patient with advanced renal
disease.2
This case illustrates diagnostic difficulties in evaluation of
chorea in an elderly diabetic patient with ESRD. Typically, an
extensive battery of tests is needed to exclude a long list of
potential etiologies. Magnetic resonance imaging, lumbar
puncture, and a serologic workup for potential autoimmune,
inflammatory, infectious, and neoplastic causes are required.
Some of the diagnoses can only be excluded retrospectively,
after a longer period of clinical follow-up. For example,
hereditary neurodegenerative diseases presenting with chorea
were excluded in this case because of spontaneous resolution
of symptoms and radiographic findings. In addition, a
thorough history and investigation of medical records is
needed to rule out exposure to common medications or
toxins producing basal ganglia dysfunction. In this case, a
complete medical history combined with an exhaustive
neurological workup (summarized in Table 1) excluded the
most common diagnoses.
Dialysis patients are prone to a number of metabolic
derangements that predispose to basal ganglia injury.
Chronic uremia due to kidney disease2 and inadequate
dialysis12,13,16 has been previously linked to basal ganglia
injury, but exact causation has not been clearly established.
Rapid correction of uremia may sometimes induce general-
ized encephalopathy attributed to cerebral edema (dialysis
disequilibrium syndrome),25 but it has not been reported to
cause isolated extrapyramidal symptoms. On the other hand,
rapid correction of chronic hyponatremia, as may occur
during dialysis treatment, has been reported to induce
extrapontine myelinolysis involving basal ganglia and striatal
pathways.3,4 In addition, animal models suggest increased
basal ganglia susceptibility to hypoxic injury in the presence
of hyponatremia.26 Dialysis patients are also more prone to
thiamine depletion17 as well as aluminum22 and manganese
toxicity.21 All three have been observed to cause movement
disorders. In this case, the patient had been on adequate
dialysis since May 2003; thus direct effect of uremia is
unlikely. She had no history of chronic hyponatremia, and
both pre- and postdialysis serum sodium levels were in the
normal range. Her thiamine, aluminum, and manganese
levels were also within normal limits.
In most,11–13 but not all,14 prior cases of bilateral basal
ganglia injury in patients with ESRD, affected patients were
also diabetics. Both hypoglycemia5,6 and hyperglycemia7,8
may rarely induce chorea. Two cases of hypoglycemia-
induced chorea in insulin-dependent diabetics on dialysis
have been reported recently.5 Diabetics with kidney disease
may be more prone to hypoglycemia due to changes in
insulin clearance and metabolism. In addition, insulin is not
significantly removed by either peritoneal or hemodialysis
due to its high molecular weight. This puts diabetic dialysis
patients at higher risk of hypoglycemia, which then can
mediate basal ganglia injury. Patients with diabetes are also
prone to ketoacidosis. Ketotic hyperglycemia,27 highly
ketogenic diet,9 as well as other organic acidemias10 have
all been reported to cause basal ganglia injury. In our patient,
there was no evidence of markedly abnormal glucose values
Table 2 | Results of additional laboratory tests
Test Result Reference range
Parathyroid hormone (pg ml1) 249 8–51
Calcium (mg per 100 ml) 8.9 8.4–9.8
Phosphorus (mg per 100 ml). 3.7 2.5–4.3
Serum ACE (IU l1) 36 9–67
Ceruloplasmin (mg per 100 ml) 19 25–63
Serum copper (mg per 100 ml) 85 80–155
Thiamine (mg per 100 ml) 3.2 1.6–4.0
Vitamin B12 (pg ml1) 1292 279–996
Homocysteine (mmol l1) 12.8 4.4–10.8
Folate (ng ml1) 10.5 5.4–18.0
Iron (mg per 100 ml) 40 41–141
TIBC (mg per 100 ml) 208 251–406
Ferritin (ng ml1) 1035 10–150
Hemoglobin A1C (%) 7.8 —
ACE, angiotensin converting enzyme; TIBC, total iron-binding capacity.
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or anion gap acidosis on admission and during hospitaliza-
tion. Her diabetes was adequately controlled with oral agents
and she had not been receiving insulin.
Finally, chorea has been described in children following an
open cardiac surgery requiring cardiopulmonary bypass.23
The mechanism is unclear, but children who developed this
complication spent more time on pump, were more
hypothermic, and more were likely to have had a circulatory
arrest compared to age-matched controls. These data suggest
that basal ganglia injury may be induced by hypoperfusion
or, less likely, by hypothermia. Theoretically, intradialytic
hypotension in a susceptible patient with cerebral vascular
disease may lead to a similar type of ischemic injury. Patients
with diabetes and ESRD are known to carry a higher burden
of macro- and microvascular pathology. It is likely that a
patient with advanced microvascular disease in the
basal ganglia region is more susceptible to other toxic
insults, hypo/hyperglycemia, acidosis, hypoxia, and/or
hypoperfusion. There is a possibility that an undetected
episode of intradialytic hypotension superimposed on
underlying cerebral microvascular disease precipitated
symptoms in this case.
CONCLUSIONS
Our case contributes to a growing evidence for the risk of
basal ganglia injury in dialysis patients. This risk may be
greatest for diabetic patients and, as illustrated by our case, is
not limited to patients of Asian ancestry. In this case, a
comprehensive neurological workup failed to identify a
specific cause of basal ganglia injury. Larger epidemiologic
studies are needed to establish a prevalence of this disorder in
ESRD patients and explore causative associations between
basal ganglia injury, diabetes, ethnicity, and dialysis-related
risk factors.
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